Insider Transactions in Q1 2024 at Ab Cellera Biologics Inc. (ABCL)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 26
2024
|
Carl L. G. Hansen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,125
+7.14%
|
$112,250
$2.7 P/Share
|